Global retinoblastoma presentation and analysis by national income level ID Fabian, E Abdallah, SU Abdullahi, RA Abdulqader, SA Boubacar, ... JAMA oncology 6 (5), 685-695, 2020 | 286 | 2020 |
Incidence of childhood leukemia in Yogyakarta, Indonesia, 1998–2009 E Supriyadi, PH Widjajanto, I Purwanto, J Cloos, AJP Veerman, S Sutaryo Pediatric blood & cancer 57 (4), 588-593, 2011 | 50 | 2011 |
Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perceptions MN Sitaresmi, S Mostert, I Purwanto, CM Gundy, Sutaryo, AJP Veerman Journal of Pediatric Oncology Nursing 26 (4), 198-207, 2009 | 46 | 2009 |
Myeloid antigen expression in childhood acute lymphoblastic leukemia and its relevance for clinical outcome in Indonesian ALL‐2006 protocol E Supriyadi, AJP Veerman, Sutaryo, I Purwanto, PM vd Ven, J Cloos Journal of oncology 2012 (1), 135186, 2012 | 40 | 2012 |
Randomized double blind trial of ciprofloxacin prophylaxis during induction treatment in childhood acute lymphoblastic leukemia in the WK-ALL protocol in Indonesia PH Widjajanto, S Sumadiono, J Cloos, I Purwanto, S Sutaryo, ... Journal of Blood Medicine, 1-9, 2013 | 35 | 2013 |
Yogyakarta pediatric cancer registry: an international collaborative project of university gadjah mada, university of saskatchewan, and the saskatchewan cancer agency K Ali, S Sutaryo, I Purwanto, S Mulatsih, E Supriyadi, PH Widjajanto, ... Asian Pac J Cancer Prev 11 (1), 131-6, 2010 | 35 | 2010 |
Early Response to Dexamethasone as Prognostic Factor: Result from Indonesian Childhood WK‐ALL Protocol in Yogyakarta PH Widjajanto, S Sutaryo, I Purwanto, PM Ven, AJP Veerman Journal of oncology 2012 (1), 417941, 2012 | 18 | 2012 |
Kombinasi Akupuntur Serta Herbal Kunyit-Akar Manis pada Terapi Batuk Kronis IF Purwanto, A Imandiri, L Arifianti Journal of Vocation Health Studies 1 (121-125), 2018 | 7 | 2018 |
Terapi Leukemia Mieloblastik Akut Anak: ProtokolAra-C, Doxorubycinedan Etoposide $'(YV0RGLÀ NDVLNordic Society of Pediatric Hematology and Oncology (m-NOPHO) E Supriyadi, I Purwanto, PH Widjajanto Sari Pediatri 14 (6), 345-50, 2016 | 7 | 2016 |
Implementing Yogyakarta pediatric cancer registry for 16 years S Mulatsih, A Hariningrum, I Purwanto, R Oktasari Paediatrica Indonesiana 59 (4), 188-94, 2019 | 6 | 2019 |
Dexamethasone versus prednisone in childhood acute lymphoblastic leukemia treatment: Results of the Indonesian randomized trial PH Widjajanto, E Supriyadi, I Purwanto, J Cloos, AJP Veerman Journal of Cancer Therapy 8 (8), 735-750, 2017 | 6 | 2017 |
Childhood acute lymphoblastic leukemia: four years evaluation of protocols 2013 and 2016 in a single center in Indonesia, a lower‐middle‐income country S Sutaryo, PH Widjajanto, S Mulatsih, B Ardianto, AWS Pangarso, ... Pediatric Blood & Cancer 69 (11), e29875, 2022 | 4 | 2022 |
L-asparaginase: long-term results of a randomized trial of the effect of additional 3 doses during consolidation treatment in the Indonesian WK-ALL-2000 protocol PH Widjajanto, S Sumadiono, I Purwanto, S Sutaryo, AJP Veerman Journal of Pediatric Hematology/Oncology 35 (8), 597-602, 2013 | 4 | 2013 |
Infection-related mortality and infection control practices in childhood acute myeloid leukemia in a limited resource setting: Experience with the Indonesian national protocol E Supriyadi, I Purwanto, Z Widiastuti, I Armytasari, S Sandi, B Ardianto, ... Belitung Nursing Journal 10 (2), 185, 2024 | 2 | 2024 |
A province-wide childhood malignancy profiles in Indonesia (2010-2019): Yogyakarta Pediatric Cancer Registry E Supriyadi, I Purwanto, I Armytasari, J Ritter, PH Widjajanto, ... Paediatrica Indonesiana 63 (4), 226-37, 2023 | 1 | 2023 |
Implementation of adapted AML treatment in limited resources country (Indonesia National AML Protocol): Interim results E Supriyadi, I Purwanto, PH Widjajanto Pediatric Blood & Cancer 62, S155-S155, 2015 | 1 | 2015 |
HIGH INFECTION-RELATED MORTALITY IN CHILDHOOD ACUTE MYELOID LEUKEMIA IN LIMITED RESOURCES SETTING: EXPERIENCE WITH THE INDONESIAN NATIONAL PROTOCOL E Supriyadi, I Armytasari, I Purwanto, B Ardianto, P Widjajanto, G Kaspers PEDIATRIC BLOOD & CANCER 69, S585-S585, 2022 | | 2022 |
Childhood Acute Lymphoblastic Leukemia: Four Years Evaluation of Protocol 2013 and 2016 in Yogyakarta, Indonesia Single Center Study in A Low-Middle Income Country S Sutaryo, P Widjajanto, E Supriyadi, S Mulatsih, B Ardianto, A Pangarso, ... PEDIATRIC BLOOD & CANCER 68, S181-S181, 2021 | | 2021 |
High-Dose Methotrexate Potential Side Effects during Osteosarcoma Treatment in the Limited Setting: A Single-Center Experience A Pangarso, I Wijayanti, N Azizah, I Purwanto, D Wijaya, S Hani, ... PEDIATRIC BLOOD & CANCER 68, S479-S479, 2021 | | 2021 |
# 8: Survival Analysis in Childhood Acute Myeloblastic Leukemia: Do Infection and Lymphocyte-Mediated Immune Response Play a Role? B Ardianto, Christine, R Triasih, E Supriyadi, PH Widjajanto, S Mulatsih, ... Journal of the Pediatric Infectious Diseases Society 10 (Supplement_1), S17-S18, 2021 | | 2021 |